HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene therapy delivery of endostatin enhances the treatment efficacy of radiation.

AbstractBACKGROUND AND PURPOSE:
To evaluate whether sustained expression of mouse endostatin by adeno-associated virus (AAV)-mediated gene transfer can enhance the treatment efficacy of ionizing radiation.
MATERIALS AND METHODS:
Mouse endostatin was cloned into recombinant AAV (rAAV) under the control of CMV beta-actin promoter. Recombinant mouse endostatin expressed via AAV gene transfer was tested for biological activity in endothelial cells. The impact of elevated serum levels of endostatin on tumor-induced angiogenesis was evaluated using an in vivo angiogenesis assay. The anti-tumor efficacy of combining rAAV-mediated endostatin delivery with radiation was evaluated in a human colorectal tumor model (HT29).
RESULTS:
Recombinant mouse endostatin expressed through an AAV vector (rAAV-mEndo) inhibited endothelial cell proliferation (by 40-45%) and migration (by 22-33%). Intramuscular injection of rAAV-mEndo (1x10(9) i.u.) led to a sustained serum endostatin level of approximately 500 ng/ml. Compared to control animals this endostatin level was sufficient to inhibit tumor cell-induced vessel formation (37 vs. 28.5, P<0.05) and delay the growth of HT29 xenografts (time from 200 to 1,000 mm(3), 21 vs. 34.5 days, P<0.05). When combined with ionizing radiation, elevated serum endostatin levels significantly enhanced the time for tumors to grow from 200 to 1,000 mm(3) (radiation, 34 days; endostatin plus radiation, 50 days, P<0.05).
CONCLUSION:
The delivery of endostatin via rAAV vectors may provide an effective means of enhancing the anti-tumor efficacy of radiation therapy.
AuthorsWenyin Shi, Christian Teschendorf, Nicholas Muzyczka, Dietmar W Siemann
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 66 Issue 1 Pg. 1-9 (Jan 2003) ISSN: 0167-8140 [Print] Ireland
PMID12559515 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endostatins
  • Peptide Fragments
  • Collagen
Topics
  • Animals
  • Cell Division (physiology)
  • Cell Movement (physiology)
  • Collagen (administration & dosage)
  • Colorectal Neoplasms (blood supply, radiotherapy)
  • Combined Modality Therapy
  • Endostatins
  • Endothelium, Vascular (pathology, physiology)
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Genetic Vectors
  • Humans
  • Mice
  • Models, Genetic
  • Neovascularization, Pathologic (prevention & control)
  • Peptide Fragments (administration & dosage)
  • Probability
  • Sensitivity and Specificity
  • Transplantation, Heterologous
  • Tumor Cells, Cultured (radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: